ELEVANCE HEALTH DL-,01/ US0367521038 /
11/7/2024 8:00:50 AM | Chg. +5.40 | Volume | Bid2:00:03 PM | Ask2:00:03 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
398.00EUR | +1.38% | 0 Turnover: 0.00 |
398.10Bid Size: 30 | 401.40Ask Size: 30 | 92.66 bill.EUR | - | - |
Assets
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,738.3000 | 1,801.5000 | 1,944.3000 | 2,019.8000 | 1,977.9000 | ||||||
Intangible Assets | 9,102.8000 | 8,441 | 7,958.1000 | 8,158 | 7,964.9000 | ||||||
Long-Term Investments | - | - | 2,231.8000 | 2,630.3000 | 2,796.3000 | ||||||
Fixed Assets | - | - | 29,836.1000 | 30,855.7000 | 30,768.2000 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | - | - | - | 11,943.6000 | 14,426.9000 | ||||||
Cash and Cash Equivalents | 2,484.6000 | 1,582.1000 | 2,151.7000 | 2,113.5000 | 4,075.3000 | ||||||
Current Assets | 28,268.4000 | 29,745.8000 | 32,228.9000 | 30,862.1000 | 34,314.9000 | ||||||
Total Assets | 58,955.4000 | 59,574.5000 | 62,065 | 61,717.8000 | 65,083.1000 |
Liabilities
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 3,132.5000 | 3,426.3000 | - | 10,888.6000 | 11,907.5000 | ||||||
Long-term debt | - | - | 14,127.2000 | 15,324.5000 | 14,358.5000 | ||||||
Liabilities to Banks | 250 | 400 | 400 | 540 | 440 | ||||||
Provisions | 4,131.8000 | 4,048.2000 | 3,897.3000 | 3,262.3000 | 3,446 | ||||||
Liabilities | 35,152.7000 | 34,809.3000 | 37,813.7000 | 38,673.7000 | 39,982.7000 | ||||||
Share Capital | 3 | 2.9000 | - | 2.6000 | 2.6000 | ||||||
Total Equity | 23,802.7000 | 24,765.2000 | 24,251.3000 | 23,044.1000 | 25,100.4000 | ||||||
Minority Interests | 0.0000 | 0.0000 | - | - | - | ||||||
Total liabilities equity | 58,955.4000 | 59,574.5000 | 62,065 | 61,717.8000 | 65,083.1000 |
Income Statement
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 61,711.7000 | 71,023.5000 | 73,874.1000 | 79,156.5000 | 84,863 | ||||||
Depreciation (total) | 245.1000 | 245.3000 | 220.9000 | 230.1000 | 192.3000 | ||||||
Operating Result | 4,377.3000 | 4,442.9000 | 4,418.4000 | 4,753.1000 | 4,801.7000 | ||||||
Interest Income | -511.8000 | -602.7000 | 600.7000 | -653 | -723 | ||||||
Income Before Taxes | 3,865.5000 | 3,840.2000 | 4,368.1000 | 4,631 | 4,555.4000 | ||||||
Income Taxes | 1,210 | 1,205.9000 | 1,808 | 2,071 | 2,085.6000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | - | - | - | ||||||
Net Income | 2,655.5000 | 2,489.7000 | 2,569.7000 | 2,560 | 2,469.8000 |
Per Share
Cash Flow
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 2,744.6000 | 3,052.3000 | 3,369.3000 | 4,116 | 3,204.5000 | ||||||
Cash Flow from Investing Activities | -4,551.6000 | -2,234.4000 | -974.9000 | -1,151.5000 | -513.9000 | ||||||
Cash Flow from Financing | 2,088.9000 | -1,717.8000 | -1,822.5000 | -2,997.4000 | -732.9000 | ||||||
Decrease / Increase in Cash | 283 | -897.7000 | 564.8000 | -38.2000 | 1,961.8000 | ||||||
Employees | 43,500 | 48,200 | 51,500 | 53,000 | 53,000 |